feed,title,long_url,short_url
Benzinga,Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles,https://benzinga.com/general/biotech/23/06/32779156/astellas-pharma-licenses-promising-gene-therapy-kt430-from-kate-therapeutics-amidst-clinical-hurd,https://da.gd/HNxvT1
